Skip to Content

Indiva Ltd NDVAF

Morningstar Rating
$0.06 −0.01 (11.88%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NDVAF is trading within a range we consider fairly valued.
Price
$0.06
Fair Value
$7.42
Uncertainty
Extreme
1-Star Price
$8.69
5-Star Price
$8.79
Economic Moat
Rbt
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NDVAF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.07
Day Range
$0.060.06
52-Week Range
$0.010.09
Bid/Ask
$0.05 / $0.07
Market Cap
$10.98 Mil
Volume/Avg
51,545 / 60,863

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.42
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Indiva Ltd sets the standard for quality and innovation in cannabis. As a Canadian licensed producer, the company produces and distributes award-winning cannabis products nationally, including Bhang Chocolate, Wana Sour Gummies, Slow Ride Bakery Cookies, Jewels Chewable Tablets, Ruby Cannabis Sugar, Sapphire Cannabis Salt, as well as capsules, pre-rolls and premium flower under the INDIVA and Artisan Batch brands.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
142

Valuation

Metric
NDVAF
Price/Earnings (Normalized)
Price/Book Value
47.74
Price/Sales
0.42
Price/Cash Flow
Price/Earnings
NDVAF

Financial Strength

Metric
NDVAF
Quick Ratio
0.58
Current Ratio
0.85
Interest Coverage
−0.52
Quick Ratio
NDVAF

Profitability

Metric
NDVAF
Return on Assets (Normalized)
−15.40%
Return on Equity (Normalized)
−356.26%
Return on Invested Capital (Normalized)
−5.35%
Return on Assets
NDVAF
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ADpxg$90.3 Bil
MKKGY
Merck KGaA ADRLqzvjbw$74.8 Bil
HLN
Haleon PLC ADRTfqt$38.3 Bil
VTRS
Viatris IncDzgl$16.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRNbb$13.0 Bil
CTLT
Catalent IncDnmwhrv$10.6 Bil
PRGO
Perrigo Co PLCCzdfq$4.4 Bil
CURLF
Curaleaf Holdings IncRsymm$3.9 Bil
PBH
Prestige Consumer Healthcare IncYwyggx$3.5 Bil
GTBIF
Green Thumb Industries IncWfly$3.4 Bil

Sponsor Center